Korro Bio, Inc.

KRRO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$84-$81-$58-$22
Dep. & Amort.$4$4$3$2
Deferred Tax$0$0-$0$0
Stock-Based Comp.$4$2$1$1
Change in WC$14$4-$1$1
Other Non-Cash$2$4$2-$13
Operating Cash Flow-$60-$67-$54-$32
Investing Activities
PP&E Inv.-$18-$8-$5-$4
Net Acquisitions$0$0$0$0
Inv. Purchases-$146$0-$37-$35
Inv. Sales/Matur.$41$19$53$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$123$11$11-$40
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$67$117$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$71-$0$116
Financing Cash Flow$69$188$0$116
Forex Effect-$0$0$0$0
Net Chg. in Cash-$114$132-$43$44
Supplemental Information
Beg. Cash$173$41$84$40
End Cash$59$173$41$84
Free Cash Flow-$78-$75-$59-$37
Korro Bio, Inc. (KRRO) Financial Statements & Key Stats | AlphaPilot